Lek is the most reputable employer in Slovenia

  • The participants in a survey measuring the reputation of employers and carried out by the recruitment portal MojeDelo.com, have recognised Lek as the most reputable employer in 2019.
  • Lek, which has ranked amongst the top reputable employers in all previous surveys, has received the title of the most reputable employer for the second time.
  • The company acknowledges that empowered, curious and inspired associates are a key driver in achieving business success.
5. 12. 2019

Lek, which is a part of Novartis, has received the prestigious title of the most reputable employer. This title has been bestowed to Slovenian employers by the recruitment portal MojeDelo.com for ninth consecutive years. This year, the reputation measuring survey has been carried out for the first time in cooperation with the leading European company in the field of employer brand management, the Swedish company Universum Global.  

In this year’s survey, more than 19,000 respondents took part, including professionals (academic and non-academic) and students, who were assessing the reputation of Slovenian employers according to the following criteria: knowledge of a company as an employer, considering a company as a potential employer, the attractiveness of a company as an employer, potential applications for open jobs positions in a company and the most common associations that respondents ascribe to each employer. Lek, which ranked among the top reputable employers in all previous surveys, received the title the most reputable employer for the second time, the first time was in 2013. 

At the ceremony at Brdo pri Kranju, the recognition award was received on behalf of the company by Ksenija Butenko Černe, Head Legal and a member of the Board of Management of Lek. She said: »Lek, which is part of Novartis, is proud to have been chosen as the most reputable employer of the year, both in absolute as well as in a number of individual categories. This shows that in the year that is behind us, which was very challenging as we, as part of Novartis, are undergoing a series of transformations on the journey of a new strategy, managed to maintain and upgrade our role as a responsible employer. This acknowledgement is a proof that we succeeded, also through the transformation of Novartis culture, to create an environment for our associates where everyone is inspired, curious and unbossed.

Together we are achieving demanding goals and creating an inspiring working environment and organisational culture enabling each and every one to develop. We could not fulfil our mission without them, our motivated, committed and fulfilled associates, therefore thank you to all of them. I am convinced that together we will continue to build and strengthen the reputation of Lek as a dynamic, ethical and trustworthy pharmaceutical company.  

I am proud that as a member of the Board of Management and a Lek and Novartis employee can confirm that we, as a responsible employer, will continue to strengthen a curious and inspiring organisation culture enabling the personal and professional development of each and every associate. This also fulfils our goal which is to become the most successful global pharmaceutical company improving and extending people’s lives.«

In addition to The Most Reputable Employer 2019 recognition, Lek has also attained the first place amongst the employers of choice as voted by students, experts in social sciences, experts in natural sciences, as well as first place in the category Pharmacy and Biotechnology, Chemical Industry.

* * *

Novartis is the leading provider of medicines in Slovenia, where Lek, Novartis Pharma Services and Sandoz, operate. Together we are building and maintaining the reputation of a dynamic, ethical, and trusted pharmaceutical company. Lek develops, manufactures, and markets effective, safe, and high quality medicines and active pharmaceutical ingredients. With our knowledge, quality, and experience we have gained an important role in Novartis' organizational structure, especially in the Novartis Technical Operations, Global Drug Development, Novartis Business Services, and the generic division Sandoz. We are the leading Sandoz development center, and one of the key development sites for technologically complex projects. We invest a great deal in the development, education, and training of our employees. Over the last seven years, the company has created more than 2,250 jobs, making us one of the biggest employers in Slovenia. Novartis invested in Slovenia more than EUR 2.3 billion since 2003. 

About Sandoz
Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access to healthcare by developing and commercializing novel, affordable approaches that address unmet medical need. Our broad portfolio of high-quality medicines, covering all major therapeutic areas and increasingly focused on value-adding differentiated medicines, accounted for 2018 sales of USD 9.9 billion. Sandoz is headquartered in Holzkirchen, in Germany’s Greater Munich area.

Sandoz is on Twitter. Sign up to follow @SandozGlobal at http://twitter.com/Sandoz_Global.

About Novartis
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 108 thousand people of more than 140 nationalities work at Novartis around the world. Find out more at www.novartis.com. 

* * *

This press release contains statements and conclusions based on projections of Lek’s future business operations. These estimates are derived from the best information currently available. In case these forecasts prove unreliable, the actual results could prove different from those projected.

- end -

For additional information contact:
Katarina Klemenc
Corporate Communications 
Lek Pharmaceuticals d. d.
Phone: +386 1 580 22 43